Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Compare credit cards to find the one with the best rewards program. Make an informed choice and maximize your benefits.
27,943 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A Tucson-based GoFundMe campaign seeks bitcoin to spur leads in the Nancy Guthrie abduction, raising a small portion ...
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Oracle is reshaping its business from database software to a cloud infrastructure powerhouse, fueled by surging backl...
Cramer confronted his past mega-cap bets on Mad Money, pivoting to a bullish view on Corning as supplier demand remai...
AVAV is set to report Q3 results after the close. Analysts expect revenue around $203 million and non-GAAP EPS near $...
Private SpaceX uses extended lockups for insiders, signaling a disciplined cash strategy. This article breaks down wh...
A landmark court ruling opens a path for refunds on tariffs. Americans demanding refunds from tariffs are turning to ...
A renewed wave of active investors is reshaping the discount broker scene. Charles Schwab stands out, quietly convert...
FTX will begin a fourth distribution to creditors, totaling $2.2 billion, starting March 31. The move comes as the es...
Air-taxi darlings Joby, Archer, and EHang have fallen sharply in 2026 as cert timelines and cash burn loom large. Inv...
Shield AI's new CEO asserts the company is at a pivotal moment, as its battlefield-tested drones and software shift f...